Core Peptides ARA-290 – 16MG

Core Peptides ARA-290 – 16MG

Core Peptides ARA-290 – 16MG is a specialized synthetic peptide research material supplied for professional laboratory and scientific research applications. ARA-290 is an experimental peptide derived from a region of erythropoietin (EPO) and has been investigated in preclinical research for its interactions with tissue-protective and cellular signaling pathways.

Supplied in a convenient 16 mg quantity, this product is intended for controlled laboratory investigations involving peptide characterization, molecular interactions, cellular signaling, and related areas of biomedical research.

Product Highlights

• Product: ARA-290
• Quantity: 16 mg
• Category: Synthetic peptide research material
• Origin: Erythropoietin-derived peptide
• Research areas: Cellular signaling, tissue-protective pathways, peptide characterization, and preclinical research
• Format: Convenient 16 mg research quantity
• Intended application: Professional laboratory and scientific research

Research Applications

ARA-290 has been studied experimentally for its potential interactions with pathways associated with cellular protection, inflammation, tissue responses, and neural biology. Researchers may use ARA-290 as a research material when investigating peptide-mediated signaling, molecular mechanisms, cellular responses, and related biological processes.

Its defined peptide structure also makes it suitable for analytical characterization and controlled biochemical research.

Quality & Documentation

For reliable research applications, researchers should consult the accompanying Certificate of Analysis (COA) and technical documentation for batch-specific information, including identity, purity, analytical testing, storage conditions, and other applicable specifications.

Research Use Only

Core Peptides ARA-290 – 16MG is intended strictly for laboratory research purposes. It is not intended for human or veterinary consumption, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition.

All handling and experimental use should be conducted by appropriately qualified personnel in accordance with established laboratory safety procedures and applicable regulations.